Imerys S.A. (IMYSF)
OTCMKTS · Delayed Price · Currency is USD
25.02
0.00 (0.00%)
At close: Mar 13, 2026
Imerys Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 3,384 | 3,605 | 3,794 | 4,282 | 3,665 |
Revenue Growth (YoY) | -6.14% | -4.99% | -11.38% | 16.83% | -3.52% |
Cost of Revenue | 1,194 | 1,280 | 1,461 | 1,592 | 1,287 |
Gross Profit | 2,190 | 2,325 | 2,333 | 2,690 | 2,378 |
Selling, General & Admin | 1,669 | 1,757 | 1,773 | 1,969 | 1,733 |
Other Operating Expenses | -2.3 | -8.4 | -3.5 | 11.6 | 7.3 |
Operating Expenses | 1,970 | 2,041 | 2,069 | 2,283 | 2,040 |
Operating Income | 220 | 283.3 | 264.3 | 406.4 | 337.4 |
Interest Expense | -64 | -66.4 | -41 | -38 | -36.5 |
Interest & Investment Income | 7.4 | 35 | 16.7 | 5.1 | 2.6 |
Earnings From Equity Investments | 30.6 | 109.5 | 89.5 | 26.6 | 12.8 |
Currency Exchange Gain (Loss) | 2.1 | -7.6 | 0.3 | -5.9 | -2.2 |
Other Non Operating Income (Expenses) | -2.5 | -3.2 | -5 | -5.1 | 3 |
EBT Excluding Unusual Items | 193.6 | 350.6 | 324.8 | 389.1 | 317.1 |
Merger & Restructuring Charges | -28.6 | -15.2 | -30.5 | -24.8 | -82 |
Impairment of Goodwill | -469.4 | - | -5.4 | -108 | - |
Gain (Loss) on Sale of Assets | -8.2 | -343.1 | -12.6 | 22.2 | 0.9 |
Asset Writedown | -67.1 | -20.9 | -210.2 | -18 | - |
Other Unusual Items | -1.8 | -2.5 | 3.2 | 7.6 | 14.4 |
Pretax Income | -381.5 | -31.1 | 69.3 | 268.1 | 250.4 |
Income Tax Expense | 30.1 | 61.5 | 60.4 | 91 | 68.2 |
Earnings From Continuing Operations | -411.6 | -92.6 | 8.9 | 177.1 | 182.2 |
Earnings From Discontinued Operations | - | - | 44.9 | 64.3 | 59.3 |
Net Income to Company | -411.6 | -92.6 | 53.8 | 241.4 | 241.5 |
Minority Interest in Earnings | 2.8 | -2.4 | -2.5 | -4.2 | -1.4 |
Net Income | -408.8 | -95 | 51.3 | 237.2 | 240.1 |
Net Income to Common | -408.8 | -95 | 51.3 | 237.2 | 240.1 |
Net Income Growth | - | - | -78.37% | -1.21% | 697.67% |
Shares Outstanding (Basic) | 85 | 85 | 85 | 85 | 85 |
Shares Outstanding (Diluted) | 85 | 85 | 86 | 86 | 86 |
Shares Change (YoY) | -0.01% | -1.41% | -0.19% | -0.21% | 3.70% |
EPS (Basic) | -4.83 | -1.12 | 0.61 | 2.80 | 2.84 |
EPS (Diluted) | -4.83 | -1.12 | 0.61 | 2.76 | 2.79 |
EPS Growth | - | - | -78.00% | -1.09% | 674.59% |
Free Cash Flow | 128.6 | 121.3 | 221.7 | 106.9 | 205.9 |
Free Cash Flow Per Share | 1.52 | 1.43 | 2.58 | 1.24 | 2.39 |
Dividend Per Share | 0.750 | 1.450 | 1.350 | 1.500 | 1.550 |
Dividend Growth | -48.28% | 7.41% | -10.00% | -3.23% | 34.78% |
Gross Margin | 64.72% | 64.48% | 61.49% | 62.82% | 64.88% |
Operating Margin | 6.50% | 7.86% | 6.97% | 9.49% | 9.21% |
Profit Margin | -12.08% | -2.63% | 1.35% | 5.54% | 6.55% |
Free Cash Flow Margin | 3.80% | 3.36% | 5.84% | 2.50% | 5.62% |
EBITDA | 451.6 | 507 | 500.1 | 657.1 | 593.9 |
EBITDA Margin | 13.35% | 14.06% | 13.18% | 15.35% | 16.21% |
D&A For EBITDA | 231.6 | 223.7 | 235.8 | 250.7 | 256.5 |
EBIT | 220 | 283.3 | 264.3 | 406.4 | 337.4 |
EBIT Margin | 6.50% | 7.86% | 6.97% | 9.49% | 9.21% |
Effective Tax Rate | - | - | 87.16% | 33.94% | 27.24% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.